In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Misonix buys Solsys Medical for $97mm plus net debt; acquisition closes at $109mm

Executive Summary

Misonix Inc. penned a definitive agreement to acquire privately held regenerative medicine firm Solsys Medical LLC in an all-stock transaction. Misonix will issue approximately 5.7mm new shares valued at $97mm (based on the market average), and will also assume $20mm in outstanding secured debt.

Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Stock

Related Companies